| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $218.7M | +3024.4% |
| R&D Expense | $314.7M | +6.8% |
| SG&A Expense | $63.3M | +61.1% |
| Operating Income | -$159.3M | +51.3% |
| Income Tax | $0 | — |
| Net Income | -$113.7M | +58.6% |
| EPS (Basic) | -$1.28 | +61.9% |
| EPS (Diluted) | -$1.28 | +61.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.8M | +33.7% |
| Short-term Investments | $526.6M | -11.0% |
| Current Assets | $666.7M | -3.3% |
| Total Assets | $1.11B | -1.3% |
| Current Liabilities | $58.8M | +27.7% |
| Total Liabilities | $86.4M | +33.0% |
| Stockholders' Equity | $1.02B | -3.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$71.1M | +71.3% |
| Capital Expenditures | $2.4M | -38.6% |
| Investing Cash Flow | $70.0M | +113.9% |
| Financing Cash Flow | $29.8M | -95.6% |
| Free Cash Flow | -$73.5M | +70.8% |